Methods and kits for improving global gene expression analysis of human blood, plasma and/or serum derived RNA
Disclosed are methods and kits for improving global gene expression analysis for a population of RNA molecules derived from a human blood, plasma and/or serum sample. In an embodiment, the method comprises the step of selectively depleting 5′-RNAY4 fragments from the population of RNA molecules or selectively blocking 5′-RNAY4 fragments within the RNA population. The 5′-RNAY4 depleted or 5′-RNAY4 blocked population of RNA can be used in a variety of global gene expression analysis protocols, including next generation sequencing. In a further embodiment, the method comprises selectively depleting or blocking miR-486-5p fragments within the RNA population. The miR-486-5p depleted or miR-486-5p blocked population of RNA can also be used in global gene expression analysis protocols, including next generation sequencing. The kit comprises oligonucleotide probes comprising a nucleotide sequence that is the complement to a nucleotide sequence of the 5′ end of the RNAY4 and/or oligonucleotide probes comprising a nucleotide sequence that is the complement to a nucleotide sequence of miR-486-5p.
1. A method of improving global gene expression analysis for a population of small RNA molecules derived from human blood, plasma and/or serum, the method comprising the step of depleting 5′-RNAY4 fragments and/or miR-486-5p fragments from the population of small RNA molecules, wherein the step of depleting 5′-RNAY4 fragments and/or miR-486-5p fragments from the population of small RNA molecules comprises:
adding 5′-RNAY4 specific oligonucleotide probes and/or miR-486-5p specific oligonucleotide probes to a sample containing the population of small RNA molecules, wherein each 5′-RNAY4 specific oligonucleotide probe comprises a nucleotide sequence that is the complement to a nucleotide sequence of the 5′ end of RNAY4 and each miR-486-5p specific oligonucleotide probes comprises a nucleotide sequence that is the complement to a nucleotide sequence of miR-486-5p;
forming a complex between one or more 5′-RNAY4 fragments and a 5′-RNAY4 specific oligonucleotide probe and/or forming a complex between one or more miR-486-5p fragments and a miR-486-5p specific oligonucleotide probe; and
removing the 5′-RNAY4:oligonucleotide complexes and/or the miR-486-5p:oligonucleotide complexes from the sample, wherein the remaining sample contains a 5′-RNAY4 and/or miR-486-5p depleted population of small RNA molecules;
wherein the step of removing the 5′-RNAY4:oligonucleotide complexes and/or miR-486-5p:oligonucleotide complexes from the sample comprises:
combining the sample with a binding buffer, an alcohol and a silicon carbide slurry to provide a binding mixture, wherein the alcohol concentration of the binding mixture is about 1-30% (v/v) to affect selective binding of the 5′-RNAY4:oligonucleotide complexes and/or miR-486-5p:oligonucleotide complexes to the silicon carbide;
removing the 5′-RNAY4:oligonucleotide complex and/or miR-486-5p:oligonucleotide complex bound SiC from the sample; and
collecting the remaining sample containing the 5′-RNAY4 and/or miR-486-5p depleted population of small RNA molecules.
2. A method of improving global gene expression analysis for a population of small RNA molecules derived from human blood, plasma and/or serum, the method comprising the step of depleting 5′-RNAY4 fragments and/or miR-486-5p fragments from the population of small RNA molecules, wherein the step of depleting 5′-RNAY4 fragments and/or miR-486-5p fragments from the population of small RNA molecules comprises:
adding 5′-RNAY4 specific oligonucleotide probes and/or miR-486-5p specific oligonucleotide probes to a sample containing the population of small RNA molecules, wherein each 5′-RNAY4 specific oligonucleotide probe comprises a nucleotide sequence that is the complement to a nucleotide sequence of the 5′ end of RNAY4 and each miR-486-5p specific oligonucleotide probes comprises a nucleotide sequence that is the complement to a nucleotide sequence of miR-486-5p;
forming a complex between one or more 5′-RNAY4 fragments and a 5′-RNAY4 specific oligonucleotide probe and/or forming a complex between one or more miR-486-5p fragments and a miR-486-5p specific oligonucleotide probe; and
removing the 5′-RNAY4:oligonucleotide complexes and/or the miR-486-5p:oligonucleotide complexes from the sample, wherein the remaining sample contains a 5′-RNAY4 and/or miR-486-5p depleted population of small RNA molecules;
wherein the step of removing the 5′-RNAY4:oligonucleotide complexes and/or miR-486-5p:oligonucleotide complexes comprises:
combining the sample with a binding buffer and alcohol to provide a binding mixture;
applying the binding mixture to a silicon carbide column, wherein the alcohol concentration of the binding mixture is about 1-30% (v/v) to affect selective binding of the 5′-RNAY4:oligonucleotide complexes and/or miR-486-5p:oligonucleotide complexes to the silicon carbide;
collecting the column flowthrough containing the 5′-RNAY4 and/or miR-486-5p depleted population of small RNA molecules.
3. The method of claim 1 , wherein the alcohol is ethanol and the alcohol concentration of the binding mixture is about 1-10% (v/v).
4. The method of claim 2 , wherein the alcohol is ethanol and the alcohol concentration of the binding mixture is about 1-10% (v/v).